ZIMBABWE’S pharmaceutical sector has expanded by 50 percent since 2021, with the number of local manufacturers rising from 10 to 15. The Medicines Control Authority of Zimbabwe (MCAZ) attributes this growth to strategic government interventions, including tax exemptions on imported pharmaceutical raw materials and zero-rated value added tax on locally produced medicines. These measures were…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions